Press Release: Palladyne AI Reports Fourth Quarter and Full Year 2025 Results and Reiterates 2026 Revenue Guidance of $24 to $27 Million

Dow Jones03-05

2026 revenue guidance implies 357% to 415% year-over-year growth, with backlog increasing more than 30% since year-end to nearly $18 million midway through the first quarter

2025 culminated in structural repositioning following November acquisitions

Launch of Palladyne Defense and commercialization of Palladyne IQ 2.0 position Company for execution in 2026

SALT LAKE CITY--(BUSINESS WIRE)--March 05, 2026-- 

Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) ("Palladyne AI"), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, advanced avionics, precision-manufactured components, UAVs, and advanced aerospace engineering services, today announced financial results for the fourth quarter and full year ended December 31, 2025.

Ben Wolff, President and Chief Executive Officer of Palladyne AI, commented:

"2025 was a year of operational validation that culminated in structural transformation. In November, we completed the acquisitions of GuideTech, Warnke Precision Machining and MKR Fabricators and launched Palladyne Defense. That repositioning expanded our capabilities beyond autonomy software to include advanced avionics, engineering services, proprietary airframe and missile development and certified U.S.-based manufacturing. We exited 2025 as a fundamentally different company, with expanded backlog, deeper defense engagement and an integrated autonomy-to-manufacturing stack aligned with evolving Department of War priorities.

"Over the past few months, we have moved decisively to execute across the defense and commercial parts of our business. We commercially released Palladyne IQ 2.0, integrating feedback from potential customers into its development, and recently signed our first customer for the product. We also introduced IntelliSwarm, integrating SwarmOS into the BRAIN X2 flight module, and demonstrated collaborative autonomy between our recently branded Gremlin-X$(TM)$ (formerly Project Banshee) platform running IntelliSwarm and multiple Red Cat platforms operating with SwarmOS, validating distributed, multi-platform collaboration in real-world environments.

"We also established our presence in the space domain. Through our satellite-related development work with the Air Force Research Laboratory, we are extending SwarmOS capabilities to integrate communications with space-based systems. Separately, our engagement with Portal Space Systems advances propulsion design for next-generation space platforms and establishes a foundation for potential future collaboration surrounding collaborative autonomy."

Recent Strategic and Operational Highlights

   --  Launched Palladyne Defense following the acquisitions of GuideTech, 
      Warnke Precision Machining and MKR Fabricators, integrating autonomy 
      software, advanced avionics engineering and design, components, 
      proprietary UAVs and missile systems, and certified U.S.-based 
      manufacturing; 
 
   --  Commercially released Palladyne IQ 2.0 and signed an initial customer 
      following customer-driven refinement throughout 2025; 
 
   --  Hired Matt Muta as President of Commercial and Industrial to focus on 
      capturing commercial opportunities; 
 
   --  Branded Project Banshee (next-generation autonomous UAV mini-bomber 
      platform currently under development) as Gremlin-X; 
 
   --  Demonstrated collaborative autonomous swarming between the Gremlin-X 
      platform utilizing IntelliSwarm, and multiple Red Cat platforms operating 
      with SwarmOS; 
 
   --  Expanded into the space domain through satellite-related development 
      work with the Air Force Research Laboratory and propulsion design 
      engagement with Portal Space Systems; 
 
   --  Progressed development milestones across Gremlin-X and new BRAIN 
      variants; 
 
   --  Secured missile propulsion subsystem contract from a new defense prime 
      customer; and 
 
   --  Strengthened intellectual property portfolio through a new patent 
      issuance supporting advanced swarming and decentralized autonomy 
      architectures and filed four new patent applications related to 
      Palladyne's AI software products and technologies. 

Fourth Quarter 2025 Financial Highlights (vs. fourth quarter 2024)

   --  Revenue increased 118% to $1.7 million compared to $0.8 million; 
 
   --  Operating loss of ($9.3) million compared to ($6.5) million; 
 
   --  GAAP net loss and basic and diluted loss per share (EPS) of ($1.5) 
      million, and ($0.04), compared to ($53.0) million, and ($1.75); 
 
   --  *Non-GAAP net loss and Non-GAAP EPS of ($6.9) million, and ($0.16), 
      compared to ($5.2) million, and ($0.17); 
 
   --  Cash, cash equivalents and marketable securities totaled $47.0 million 
      at December 31, 2025; 
 
   --  Backlog as of December 31, 2025, was $13.5 million. 

Full Year 2025 Financial Highlights (vs. full year 2024)

   --  Revenue decreased 33% to $5.2 million compared to $7.8 million; 
 
   --  Operating loss of ($32.4) million compared to ($26.9) million; 
 
   --  GAAP net income and diluted EPS of $10.0 million, and $0.24, compared 
      to a net loss of ($72.6) million, and ($2.71); 
 
   --  *Non-GAAP net loss and Non-GAAP EPS of ($25.2) million, and ($0.60), 
      compared to ($22.6) million, and ($0.84). 

*see GAAP to Non-GAAP reconciliation at the end of this press release

2026 Outlook

The Company reiterates its previously announced full year 2026 revenue guidance of $24 million to $27 million, representing expected year-over-year growth of approximately 357% to 415% compared to 2025 revenue of $5.2 million. Supporting this guidance, Palladyne AI had a contracted 12-18 month backlog of nearly $18.0 million as of mid-February 2026, a more than 30% increase since December 31, 2025.

The guidance reflects revenue contributions from acquired entities, backlog conversion and monetization of development programs secured during and following the Company's fourth quarter repositioning. Management believes recent contract wins and expanding program activity across air and space domains provide increased visibility into achieving these targets.

The Company continues to advance product maturation milestones and pursue early customer wins across Palladyne IQ 2.0, SwarmOS and BRAIN platforms while maintaining a disciplined focus on execution.

Conference Call

Palladyne AI will host a conference call today, Thursday, March 5, 2026, at 8:00 a.m. Eastern Time to discuss its financial and operational results, strategy and future opportunities.

 
Dial-in and Webcast Information 
 
                                Thursday, March 5, 2026, at 8:00 a.m. 
Date/Time:                      Eastern Time 
Toll-Free (North America):      1-877-407-0789 
Toll/International:             1-201-689-8562 
Conference Call ID:             13758938 
Webcast Link: 
https://viavid.webcasts.com/starthere.jsp?ei=1753897&tp_key=50d08a7821 
Call me(TM): Participants can use the Guest dial-in #s above and be answered 
by an operator, or click the Call me(TM) link for instant telephone access 
to the event. Call me(TM) link will be made active 15 minutes prior to the 
scheduled start time. 
https://callme.viavid.com/viavid/?callme=true&passcode=13757186&h=true&info= 
comp any&r=true&B=6 
 
 
Replay Information 
 
Toll-Free (North America)    1-844-512-2921 
Toll/International:          1-412-317-6671 
Conference Call ID:          13758938 
Expiration:                  Thursday, March 19, 2026, 11:59 p.m. Central 
                             Time 
 

About Palladyne AI

Palladyne AI is a U.S.-based technology company developing patented embodied artificial intelligence, collaborative autonomy solutions, advanced avionics, autonomous systems, advanced UAV engineering services, and precision-manufactured components for defense and industrial markets. Palladyne AI delivers secure, American-developed and operated platforms designed to meet the stringent requirements of U.S. government and public-sector customers, including data sovereignty, security, and compliance.

Palladyne AI's embodied AI is designed to operate in complex, contested, and high-risk environments, enabling distributed tasking, human-on-the-loop decision-making, degraded-communications resilience, and multi-domain coordination. Its platform-agnostic autonomy stack combines real-time sensor fusion, adaptive AI models, and edge-native orchestration - without vendor lock-in - to support autonomous and collaborative systems across air, ground, maritime, and industrial domains where performance, resilience, and trust are paramount. For more information about Palladyne AI, including GuideTech and Palladyne Defense, please visit www.palladyneai.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the capabilities or future capabilities of Palladyne AI's technology and related products, including IntelliSwarm; anticipated growth, operating scale and operating inflection of the Company; the applicability of Palladyne AI's products and technology to the space domain; 2026 expected financial performance, including expected revenue and sources of revenue; the time of customer acquisition, revenue recognition and backlog realization; the benefits of its AI software and other products and the markets for its products and services; and the applicability of IntelliSwarm and its autonomy software to different kinds of machines (such as UAVs, UGVs and ROVs); future development and qualification plans; and intended future target customers. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by, or include the words

"believes," "estimates," "expects," "projects," "forecasts," "may," "will," "should," "seeks," "plans," "scheduled," "anticipates," "intends" or "continue" or similar expressions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results, or performance to differ materially from those indicated by such statements. These forward-looking statements are based on Palladyne AI's management's current expectations and beliefs, as well as a number of assumptions concerning future events. However, there can be no assurance that the events, results, or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made, and Palladyne AI is not under any obligation and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.

Readers should carefully review the statements set forth in the reports which Palladyne AI has filed or will file from time to time with the Securities and Exchange Commission (the "SEC"), in particular the risks and uncertainties set forth in the sections of those reports entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements, " for a description of risks facing Palladyne AI and that could cause actual events, results or performance to differ from those indicated in the forward-looking statements contained herein. The documents filed by Palladyne AI with the SEC may be obtained free of charge at the SEC's website at www.sec.gov.

 
                           PALLADYNE AI CORP. 
                      CONSOLIDATED BALANCE SHEETS 
                              (unaudited) 
                    (in thousands, except share data) 
 
                                              As of 
                            ----------------------------------------- 
                             December 31, 2025     December 31, 2024 
                            -------------------   ------------------- 
 
Assets 
Current assets: 
   Cash and cash 
    equivalents             $            18,219   $            31,188 
   Marketable securities                 28,836                 8,883 
   Accounts receivable, 
    net of allowance for 
    credit losses of $0.0 
    million and $0.3 
    million at December 
    31, 2025 and 2024, 
    respectively                          1,055                   134 
   Unbilled receivables                   2,455                 1,179 
   Inventories                              339                    71 
   Prepaid expenses and 
    other current assets                  1,653                 1,275 
                                ---------------       --------------- 
Total current assets                     52,557                42,730 
Property and equipment, 
 net                                      8,889                 4,244 
Intangible assets, net                   10,430                    -- 
Goodwill                                 14,731                    -- 
Operating lease assets                    8,645                 8,841 
Other non-current assets                    460                   438 
                                ---------------       --------------- 
Total assets                $            95,712   $            56,253 
                                ===============       =============== 
Liabilities and 
stockholders' equity 
(deficit) 
Current liabilities: 
   Accounts payable         $             1,058   $               435 
   Accrued liabilities                    3,550                 2,919 
   Current operating lease 
    liabilities                           1,058                 1,079 
                                ---------------       --------------- 
Total current liabilities                 5,666                 4,433 
   Warrant liabilities                    2,772                51,396 
   Operating lease 
    liabilities                           9,725                 9,957 
   Other non-current 
   liabilities                            2,874                    -- 
                                ---------------       --------------- 
Total liabilities                        21,037                65,786 
                                ---------------       --------------- 
Commitments and 
contingencies 
Stockholders' equity 
(deficit): 
Common stock, $0.0001 par 
 value, 165,000,000 shares 
 authorized as of December 
 31, 2025 and December 31, 
 2024; 46,117,164 and 
 33,883,894 shares issued 
 and outstanding as of 
 December 31, 2025 and 
 December 31, 2024, 
 respectively                                 5                     3 
Additional paid-in capital              555,451               481,289 
Accumulated other 
 comprehensive income                        11                     6 
Accumulated deficit                    (480,792)             (490,831) 
                                ---------------       --------------- 
Total stockholders' equity 
 (deficit)                               74,675                (9,533) 
                                ---------------       --------------- 
Total liabilities and 
 stockholders' equity 
 (deficit)                  $            95,712   $            56,253 
                                ===============       =============== 
 
 
                             PALLADYNE AI CORP. 
                    CONSOLIDATED STATEMENTS OF OPERATIONS 
                                 (unaudited) 
               (in thousands, except share and per share data) 
 
                        Three Months Ended 
                           December 31,           Year Ended December 31, 
                     -------------------------   ------------------------- 
                        2025          2024          2025          2024 
                     -----------   -----------   -----------   ----------- 
Revenue, net         $     1,661   $       761   $     5,246   $     7,786 
Operating 
expenses: 
   Cost of revenue 
    (exclusive of 
    items shown 
    separately 
    below)                 1,402           554         2,690         3,488 
   Research and 
    development            3,758         2,612        12,899        10,437 
   General and 
    administrative         4,683         3,461        17,199        16,842 
   Sales and 
    marketing              1,014           618         4,744         4,134 
   Asset write-down 
    and 
    restructuring             --            --            --          (192) 
                      ----------    ----------    ----------    ---------- 
      Total 
       operating 
       expenses           10,975         7,245        37,650        34,709 
                      ----------    ----------    ----------    ---------- 
Loss from 
 operations               (9,314)       (6,484)      (32,404)      (26,923) 
Interest income, 
 net                         432           277         1,944         1,244 
Gain (loss) on 
 warrant 
 liabilities               4,630       (46,760)       37,740       (46,935) 
Other income, net            221            --           221             2 
                      ----------    ----------    ----------    ---------- 
Income (loss) 
 before income tax 
 expense                  (4,031)      (52,967)        7,501       (72,612) 
                      ----------    ----------    ----------    ---------- 
Income tax benefit 
 (expense)                 2,538            (2)        2,538            (5) 
                      ----------    ----------    ----------    ---------- 
Net income (loss)    $    (1,493)  $   (52,969)  $    10,039   $   (72,617) 
                      ==========    ==========    ==========    ========== 
Net income (loss) 
per share 
   Basic             $     (0.04)  $     (1.75)  $      0.26   $     (2.71) 
   Diluted           $     (0.04)  $     (1.75)  $      0.24   $     (2.71) 
Weighted-average 
shares used in 
computing net 
income (loss) per 
share 
   Basic              42,329,510    30,277,019    38,841,116    26,774,895 
   Diluted            42,329,510    30,277,019    42,125,932    26,774,895 
 
 
                         PALLADYNE AI CORP. 
                CONSOLIDATED STATEMENTS OF CASH FLOWS 
                             (unaudited) 
                            (in thousands) 
 
                                             Year Ended December 31, 
                                         ------------------------------- 
                                             2025             2024 
                                         -------------      --------- 
Cash flows from operating activities: 
Net income (loss)                        $      10,039      $ (72,617) 
Adjustments to reconcile net income 
(loss) to net cash used in operating 
activities: 
   Stock-based compensation                      4,447          2,805 
   Depreciation of property and 
    equipment                                      974            825 
   Amortization of intangible assets               118             -- 
   Change in fair value of warrant 
    liabilities                                (37,740)        46,935 
   Allowance for credit losses                      --            285 
   Amortization of investment discount          (1,386)           (75) 
   Deferred income tax benefit                  (2,541)            -- 
Changes in operating assets and 
liabilities, net of acquisitions: 
   Accounts receivable                           1,096            136 
   Unbilled receivable                            (960)           855 
   Inventories                                      58            994 
   Prepaid expenses and other current 
    assets                                        (132)         1,048 
   Operating lease assets & other 
    non-current assets                           1,005          1,242 
   Accounts payable                               (708)          (819) 
   Accrued liabilities and current 
    operating lease liabilities                   (904)        (3,164) 
   Operating lease liabilities                  (1,003)        (1,077) 
                                             ---------       -------- 
Net cash used in operating activities          (27,637)       (22,627) 
                                             ---------       -------- 
Cash flows from investing activities: 
   Purchases of property and equipment            (713)          (265) 
   Acquisition of a business, net of 
    cash acquired                               (5,302)            -- 
   Purchases of marketable securities          (75,563)        (8,859) 
   Maturities of marketable securities          57,000         16,000 
                                             ---------       -------- 
Net cash (used in) provided by 
 investing activities                          (24,578)         6,876 
                                             ---------       -------- 
Cash flows from financing activities: 
   Proceeds from exercise of stock 
    options                                         74            130 
   Proceeds from issuance of common 
   stock under ESPP                                148             -- 
   Proceeds from the exercise of 
   warrants                                      6,419             -- 
   Shares repurchased for payment of 
    tax withholdings                                --           (105) 
   Payment of obligations under finance 
    leases                                         (20)            (3) 
   Payment of debt obligations                  (3,696)            -- 
   Proceeds from the issuance of 
    warrants                                        --          4,432 
   Proceeds from issuance of common 
    stock                                       36,371         20,028 
   Payment of transaction costs related 
    to issuance of common stock                    (50)          (682) 
                                             ---------       -------- 
Net cash provided by financing 
 activities                                     39,246         23,800 
                                             ---------       -------- 
Net (decrease) increase in cash and 
 cash equivalents                              (12,969)         8,049 
Cash and cash equivalents at beginning 
 of period                                      31,188         23,139 
                                             ---------       -------- 
Cash and cash equivalents at end of 
 period                                  $      18,219      $  31,188 
                                             =========       ======== 
Supplemental disclosure of cash flow 
information: 
Cash paid for income taxes               $           2      $      10 
Supplemental disclosure of non-cash 
activities: 
Common stock issued in connection with 
 a business acquisition                  $      15,872      $      -- 
Purchases of property and equipment 
 financed through notes payable          $         113      $      -- 
Warrant liabilities reclassified to 
 equity upon exercise                    $      10,883      $      -- 
 
 
       PALLADYNE AI CORP. NON-GAAP 
            FINANCIAL MEASURES 
               (Unaudited) 
 

To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our financial results, we have presented in this release non-GAAP net income (loss) and non-GAAP net income (loss) per share (non-GAAP EPS), each of which are non-GAAP financial measures. Non-GAAP net income (loss) and non-GAAP EPS are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies.

We define non-GAAP net income (loss) as our GAAP measures of net income (loss) excluding the impacts of stock-based compensation expense, gain or loss on change in fair value of warrant liabilities, expenses related to business combinations and other non-recurring or non-operating expenses. We define non-GAAP EPS as non-GAAP net income (loss) divided by weighted average outstanding shares.

The most directly comparable GAAP measures to non-GAAP net income (loss) and non-GAAP EPS are net income (loss) and EPS, respectively. We believe excluding the impact of the previously listed items in calculating non-GAAP net income (loss) and non-GAAP EPS can provide a useful measure for period-to-period comparisons of our core operating performance. We monitor, and have presented in this release, non-GAAP net income (loss) and non-GAAP (EPS) because they are each a key measure used by our management and board of directors to understand and evaluate our operating performance and to establish budgets. We believe non-GAAP net income (loss) and non-GAAP EPS help identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we include in net income (loss) but not in non-GAAP net income (loss). Accordingly, we believe non-GAAP net income (loss) and non-GAAP (EPS) provide useful information to investors, analysts and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance.

Non-GAAP net income (loss) and non-GAAP (EPS) are not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of non-GAAP net income (loss) and non-GAAP EPS rather than net income (loss) and EPS, which is for each the most directly comparable financial measure calculated and presented in accordance with GAAP. In addition, the expenses and other items that we exclude in our calculations of non-GAAP net income (loss) and non-GAAP EPS may differ from the expenses and other items, if any, that other companies may exclude from non-GAAP net income (loss) and non-GAAP EPS when they report their operating results, limiting the usefulness of non-GAAP net income (loss) and non-GAAP EPS for comparative purposes.

In addition, other companies may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP net income (loss) and non-GAAP EPS as tools for comparison.

The following table reconciles non-GAAP net income (loss) to net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP (in thousands, except share and per share data):

 
                       Three Months Ended 
                          December 31,           Year Ended December 31, 
                    -------------------------   ------------------------- 
                       2025          2024          2025          2024 
                    -----------   -----------   -----------   ----------- 
Net income (loss)   $    (1,493)  $   (52,969)  $    10,039   $   (72,617) 
Non-GAAP 
adjustments: 
   Stock-based 
    compensation 
    expense               1,101           578         4,447         2,805 
   (Gain) loss on 
    warrant 
    liability            (4,630)       46,760       (37,740)       46,935 
   Asset 
    write-down and 
    restructuring 
    (1)                      --            --            --          (192) 
   Transaction 
    Expenses (2)            631           466           631           466 
   Income tax 
    benefit 
    related to 
    business 
    combinations         (2,541)           --        (2,541)           -- 
                     ----------    ----------    ----------    ---------- 
Non-GAAP net loss   $    (6,932)  $    (5,165)  $   (25,164)  $   (22,603) 
                     ==========    ==========    ==========    ========== 
Net income (loss) 
per share 
   Basic            $     (0.04)  $     (1.75)  $      0.26   $     (2.71) 
   Diluted          $     (0.04)  $     (1.75)  $      0.24   $     (2.71) 
Non-GAAP net loss 
per share 
   Basic            $     (0.16)  $     (0.17)  $     (0.65)  $     (0.84) 
   Diluted          $     (0.16)  $     (0.17)  $     (0.60)  $     (0.84) 
Weighted-average 
shares used in 
computing net 
loss per share 
   Basic             42,329,510    30,277,019    38,841,116    26,774,895 
   Diluted           42,329,510    30,277,019    42,125,932    26,774,895 
 
 
(1)    Asset write-down and restructuring benefit for the twelve months ended 
       December 31, 2024, reflects restructuring charges, net of estimate 
       adjustments, and is included within general and administrative expenses 
       within the consolidated statements of operations. 
(2)    Transaction expenses for the twelve months ended December 31, 2025, 
       primarily consisted of legal and accounting costs incurred in 
       connection with the business combinations completed in November 2025. 
       Transaction expenses for the twelve months ended December 31, 2024, 
       primarily consisting of brokerage, legal and accounting fees incurred 
       in connection with our issuance of warrants in November 2024. In both 
       periods, these costs are included within general and administrative 
       expenses within the consolidated statements of operations. 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260305148397/en/

 
    CONTACT:    Palladyne AI Investor Contact: 

Brian S. Siegel, IRC$(R)$, M.B.A.

Senior Managing Director

Hayden IR - Chicago

(346) 396-8696 (o)

brian@haydenir.com

IR@palladyneai.com

Palladyne AI Press Contact:

Heath Meyer

(858) 768-1527

PR@palladyneai.com

 
 

(END) Dow Jones Newswires

March 05, 2026 06:00 ET (11:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment